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1. Introduction 2. Materials and methods 
A new metabolite of vitamin D3 has been isolated 
from the plasma of chickens, rats and pigs given large 
doses of vitamin D3 and identified as 25-hydroxyvita- 
min Ds-26,23-lactone (25OH-Da-26,23-lactone) 
[l-3]. Four possible diastereoisomers of 25OH-Da- 
26,23-lactone have been synthesized [4-91; they have 
been directly compared to the natural 25OH-Da-26, 
23-lactone by high pressure liquid chromatography. 
The stereochemical configurations of the natural 
25-OH-D,-26,23-lactone at C-23 and C-25 positions 
were determined to be 23(S) and 25(R), respectively 
[9,10]. 23(5)25Dihydroxyvitamin D3 [23(S)25- 
(OH),Da] is a far better substrate for production of 
25-OH-Ds-26,23-lactone than is 25,26_dihydroxyvita- 
min Ds (25,26-(OH),Ds) [11].23(,!7)25@)26&ihy- 
droxyvitamin D3 [23(5)25@)26-(OH)sDs] isa better 
substrate than 23(5)25-(OH),D, in the biosynthesis 
of the 25-OH-Da-26,23-lactone [ 121. Therefore, the 
25-OH-Ds-26,23-lactone may be biosynthesized from 
25-OH-D3 by way of 23@)25-(OH),D, to 23(S)25- 
(R)26-(OH),D,. 
2.1. Compounds 
We synthesized 25-OH-D3 and lo,25-(OH)2Ds as 
in [ 13].25-OH-Da-26,23-Lactone was isolated and 
purified from the serum of rats given large doses of 
vitamin D3 as in [lo]. 
2.2. Assay for intestinal calcium transport and bone 
calcium mobilization 
The biological activity and physiological function(s) 
of the 25-OH-Ds-26,23-lactone are still unknown. 
Here, we report that in the rat that 25-OH-Ds-26,23- 
lactone slightly stimulates intestinal calcium transport 
and at the same time mediates afall in the concentra- 
tion of serum calcium. 
Male weanling rats of the Wistar strain were fed a 
vitamin D-deficient low calcium diet (Ca, 0.0036%; 
P, 0.3%; Teklab Test Diet, Madison WI) for 6 weeks. 
At the end of week 6,5 rats each (-100 g body wt) 
received an intravenous injection of 500 ng 25-OH- 
D3-26,23-lactone, 250 ng l&,25-(0H)aDs or 500 ng 
25-OH-Ds in 0.2 ml 0.2% Triton X-100 solution. The 
rats were sacrificed at the indicated times after admin- 
istration, and the intestinal calcium transport and 
serum calcium concentration were measured. The 
intestinal calcium transport assay using everted uo- 
denal sacs was done as in [ 141. Serum calcium con- 
centration was determined by the OCPC (o-cresol- 
phthalein complexone) method [ 151. 
3. Results 
Abbreviations: 25OH-D,, ZS-hydroxyvitamin D,; 25-OH-D,- 
26,23-lactone, 25-hydroxyvitamin D,-26,23 lactone; 23,25- 
(OH),D,, 23,25-dihydroxyvitamin D,; 25,26-(OH),D,, 25,26- 
dihydroxyvitamin D,; lcu,25-(OH),DJ, lor,25-dihydroxyvita- 
min D,; 23,25,26-(OH),D,, 23,25,26_trihydroxyvitamin D,; 
lor, 25-(OH),D,-26,23-lactone, lor,25-dihydroxyvitamin 
D,-26,23-lactone 
The biological activity of the isolated 25-OH-Da- 
26,23-lactone was assayed in vitamin D-deficient rats 
fed a low calcium diet. Initially, a single dose of 
500 ng 25-OH-Da-26,23-lactone was used to test its 
intestinal calcium transport activity in comparison to 
that of lc~,25-(OH)~D~ or 25-OH-Da (fig.1). The 
25-OH-Ds-26,23-lactone slightly stimulated intestinal 
calcium transport after 12 h and it reached amaxi- 
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F&l. Time-course response of intestinal calcium-transport 
system. Rats on a low calcium diet received a single intravenous 
dose of either 500 ng 25-OH-Ds-26,23-lactone (0) or 250 ng 
la,25-(OH),D, (0) or 500 ng 25-OH-D, (A) or vehicle (0) in 
0.2 ml 0.2% Triton X-100 solution. At the indicated times, 
animals were decapitated and their duodena were used for 
the determination of intestinal calcium transport. The rate of 
intestinal calcium transport is represented by the ratio of 
‘Yas+ in the serosal medium to *‘Ca’+ in the mucosal medium. 
Each point is the mean f SEM of determinations on 5 rats. 
mum 24 h after administration. After 48 h, the 
responses did not differ significantly from the control. 
On the contrary, lo,25(OH),Da and 2%OH-Da demon- 
strated a greater stimulation of intestinal calcium 
transport han did 25.OH-Ds-26,23-lactone. 
The time course of calcium mobilization from bone, 
as measured by an elevation in serum Ca’+ levels, pro- 
duced by 500 ng 25.OH-Da-26,23-lactone was com- 
pared to that produced by 250 ng la,25(OH)2Da or 
500 ng 25-OH-D3 (fig.2). The 25.OH-Da-26,23-lac- 
tone caused only a slight elevation in serum calcium 
over the first 24 h of assay. This was followed over 
the 48-96 h interval by a significant reduction in the 
serum calcium levels. However, 10,25-(OH)zDa nd 
25.OH-Da generate asignificant rise in serum Ca’+ 
levels, in accord with [ 18,191, demonstrating potent 
actions of these seco-steroids on bone calcium mobi- 
lization. 
Table 1 shows the dose-response relationship 
between 25-OH-Da-26,23-lactone and intestinal cal- 
cium transport and bone calcium mobilization. The 
intestinal calcium transport of la,25-(OH)ZDJ reached 
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Fig.2. Time-course response of bone calcium mobilization 
induced in rats by 500 ng 25-OH-D,-26,23-lactone (0) or 
250 ng la,25-(OH),D, (0) or 500 ng 25-OH-D, (A) or vehicle 
(0). Rats on a low calcium diet received a single intravenous 
dose of compound in 0.2 ml 0.2% Triton X-100 solution. At 
the indicated times, animals were decapitated, blood was 
collected, and calcium was measured in the serum by the 
OCPC method [ 151. Data are expressed as mg Ca’+/lOO ml 
serum and are the mean + SEM of 5 determinations. 
a maximum within 8 h after dosing, while that of 
25.OH-Da-26,23-lactone only reached amaximum 
24 h after administration (fig.1). The more 25.OH- 
Da-26,23-lactone is administered, the more intestinal 
calcium transport is stimulated. The potency of 
25-OH-Ds-26,23-lactone i  intestinal calcium trans- 
port was estimated to be -120.times less than that of 
lo,25-(OH)zDa. Graded doses of 25.OH-Da-26,23- 
lactone had no influence on bone calcium mobiliza- 
tion 24 h after dosing. 
Table 2 illustrates the effect of prior dosing with 
25-OH-Ds-26,23-lactone on the biological response to 
a subsequently administered dose of 1,25-(OH)zDJ. 
In agreement with the results in fig.l,2,95 h after the 
administration of the 25-OH-Da-26,23-lactone alone, 
there was apparent asignificant inhibition of bone 
calcium mobilization. Intriguingly, the prior admini- 
stration of 25.OH-Ds-26,23-lactone completely 
blocked the characteristic bone calcium mobilization 
response of 1 ,25(OH)Z-Da, while it had no inhibiting 
effect on the intestinal calcium transport of la,25- 
(OH),Da. 
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Table 1 
Dose-response relationship between 25-OH-D,-26,23-lactone and intestinal calcium 
transport and bone calcium mobilization in vitamin D-deficient rats on a low calcium diet 
Compound Dose 
(ng) 
Time 
(h) 
“Caz+ serosal/ 
Wa*+ mucosal 
Serum Ca*+ 
(w/100 ml) 
Vehicle 8 1.74 f 0.16 4.74 f 0.17 
lo,25-(OH),D, 10 8 2.48 * 0.15a 4.95 f 0.18a 
50 8 4.20 f 0.22c 5.60 + 0.18c 
100 8 5.06 f 0.31c 5.92 * 0.2oc 
250 8 5.33 f 0.28c 6.09 * 0.22c 
25-OH-D,-26,23-lactone 100 24 2.14 + 0.13a 4.80 f 0.16 
500 24 2.65 f 0.20b 4.70 i 0.18 
2500 24 3.27 f 0.24b 4.62 f 0.21 
Significantly different from control: a p < 0.05; b p < 0.01; c p < 0.001 
After 6 weeks on the vitamin D-deficient, low calcium diet, rats were divided into groups 
of 3 or 5 and each rat received a single intravenous dose of compound in 0.2 ml 0.2% 
Triton X-100 solution. Control rats received only vehicle. After 8 or 24 h, the animals 
were decapitated and intestinal calcium transport and serum calcium concentration were 
measured as in section 2. Data are expressed as mean + SEM 
4. Discussion 
We report the first detailed assessment of the bio- 
logical activity of the characterized vitamin Ds metab- 
olite, 2.5.OH-Ds-26,23-lactone. W  have employed 
biosynthetically produced 25.OH-Ds-26,23-lactone, 
independently shown to have the stereochemical con- 
figuration of 23(S) and 25(R) [9,1@]. These studies in 
the rat indicate that the naturally occurring 25.OH- 
Ds-26,23-lactone has <l% (table 1) of the activity of 
1 ,25-(OH)2-Ds in stimulating intestinal calcium trans- 
port and no capability to stimulate bone calcium 
mobilization (fig.l,2). The incubation of rachitic 
chicken kidney homogenates with 25.OEf-D,-26,23- 
lactone is known to produce substantial mounts of 
lo-25,.dihydroxyvitamin-Ds-26,23-lactone [ 1,25- 
(OH)z-Da-26,23-lactone] [ 10,171. The biological activ- 
ity of the 25.OH-Ds-26,234actone may result from 
enzymatic onversion of this seco-steroid nto the 
1 ,25-(OH)z-D3-26,23-lactone. 
Table 2 
Effect of 25-OH-D,-26,23-lactone on intestinal calcium transport and serum calcium concentration 
of vitamin D-deficient rats 
Compound given Intestinal Ca’+ transport Serum Cal+ 
(mg/lOO ml) 
Dose 1 Dose 2 “Cal+ serosal/45Ca2+ mucosal 
Vehicle 
25_OH-Ds-26,23- 
Vehicle 1.71 + 0.13 4.84 f 0.18 
lactone 
Vehicle 
25aH-D,-26,23- 
Vehicle 
la,25-(OH),D, 
1.80 t 0.09 4.14 * 0.19a 
3.96 ? 0.18a 5.82 f 0.16a 
lactone lo,25-(OH),D, 3.91 zt 0.10a 4.88 f 0.20 
Significantly different from control: a p < 0.001 
Rats fed a low calcium, vitamin D-deficient diet for 6 weeks into 4 groups of 5 rats. They received the 
first dose of 500 ng 25-OH-D,-26,23-lactone dissolved in 0.2 ml 0.2% Triton X-100 solution or 
vehicle only intravenously. After 80 h they received a second dose of 250 ng lor,25-(OH),D, dissolved 
in 0.2 ml 0.2% Trition X-100 solution or vehicle only by the same route; 15 h after the second dose, 
the animals were killed and intestinal calcium transport activity and serum calcium concentration were 
measured as in section 2. The data are expressed as the mean f SEM 
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The striking ability of the 25OH-Ds-2623.lactone 
to apparently inhibit bone calcium mobilization (fig.2; 
table 2) are novel and intriguing. Regulation of serum 
calcium levels in animals is known to be under a multi- 
factorial hormonal control involving parathyroid hor- 
mone [PTH], calcitonin and 1,25-(OH)2-Ds [ 161. Thus 
the observed reduction in serum calcium levels could 
conceivably result from an inhibition by 25.OH-Ds- 
26,23-lactone of P-D&mediated bone resorption or 
alternatively a stimulation of renal tubular calcium 
excretion or an inhibition of renal tubular calcium 
absorption. Studies are underway to evaluate these 
several possibilities. 
Also as shown in table 2, the 25.OH-Ds-26,23-lac- 
tone has a possible significant anti-vitamin action 
with respect to blocking the actions of 1 ,25-(OH)2-D3 
on bone calcium mobilization. No vitamin D analogs 
or metabolites had been identified which have an anti- 
vitamin activity for 1,25-(OH)zDs; everal compounds, 
however, have been reported to block the biological 
response of vitamin D [20,21]. However, it is possible 
that this apparent inhibition of 1,25-(OH),D, action 
is simply a separate action of the 25.OH-Ds-26,23-lac- 
tone on perturbing the renal tubular handling of cal- 
cium (see above) so that the characteristic 1,25-(OH)?- 
Da-mediated elevation in serum calcium is not detect- 
able by this experimental protocol. Future experi- 
ments will be required to evaluate how combinations 
of 1 ,25-(OH)2-Ds and 25.OH-Ds-26,23-lactone may 
regulate serum calcium levels. Only then will it be 
possible to gain insight into the physiological func- 
tion of the 25.OH-Da-26,23-lactone. 
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